Could radio waves ease menopause symptoms? new trial investigates
NCT ID NCT07419035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a non-surgical radiofrequency device can improve vaginal health and sexual function in postmenopausal women. Forty women aged 40-65 will receive either active treatment or a sham procedure over six weekly sessions. The goal is to see if this approach safely reduces common symptoms like dryness and pain without hormones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bipolar radiofrequency therapy (non-ablative device)
What this could lead to
If it works, this could offer a non-hormonal option to relieve vaginal dryness, pain, and improve sexual function in postmenopausal women.
What could go wrong
This is a small, early-stage trial with only 40 participants, and the sham control may show similar results. The benefits may be modest or not last long.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITOURINARY SYNDROME OF MENOPAUSE (GSM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Castilla-La Mancha
Toledo, Toledo, 45071, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••